Astherna is growing! Three new colleagues joined to our team!

We are excited! Three new members have joined to Astherna team! Berno Maaswinkel (CEO), Erwin van Wijk (Associate Professor in Genetics) and Irene Vázquez Domínguez (post-doctoral researcher) joined our team 1^st April 2023. They will complement the current team expertise.  Berno as a CEO will lead the company, Erwin will focus on the development of an RNA treatment for Usher syndrome while Irene will be focused on pre-clinical testing.